Zheng A - Search Results

1

Mutual communication between radiosensitive and radioresistant esophageal cancer cells modulates their radiosensitivity.

Xie C, Chen X, Chen Y, Wang X, Zuo J, Zheng A, Luo Z, Cheng X, Zhong S, Jiang J, Du J, Zhao Y, Jiang P, Zhang W, Chen D, Pan H, Shen L, Zhu B, Zhou Q, Xu Y, Tang KF. Xie C, et al. Among authors: zheng a. Cell Death Dis. 2023 Dec 19;14(12):846. doi: 10.1038/s41419-023-06307-9. Cell Death Dis. 2023. PMID: 38114473 Free PMC article.

2

Upregulation of FAM50A promotes cancer development.

Hu MZ, Dai ZZ, Ji HY, Zheng AQ, Liang H, Shen MM, Liu JN, Tang KF, Zhu SJ, Wang KJ. Hu MZ, et al. Med Oncol. 2023 Jul 1;40(8):217. doi: 10.1007/s12032-023-02072-z. Med Oncol. 2023. PMID: 37393403

3

Upregulation of CELSR1 expression promotes ovarian cancer cell proliferation, migration, and invasion.

Zuo J, Zheng A, Wang X, Luo Z, Chen Y, Cheng X, Zhao Y, Zhou X, Tang KF, Du X. Zuo J, et al. Among authors: zheng a. Med Oncol. 2023 Dec 9;41(1):10. doi: 10.1007/s12032-023-02232-1. Med Oncol. 2023. PMID: 38070011

4

T cell receptor and B cell receptor exhibit unique signatures in tumor and adjacent non-tumor tissues of hepatocellular carcinoma.

Xie S, Yan R, Zheng A, Shi M, Tang L, Li X, Liu J, Gan Y, Wang Y, Jiang D, Liu L, Wu H, Wang Z. Xie S, et al. Among authors: zheng a. Front Immunol. 2023 May 29;14:1161417. doi: 10.3389/fimmu.2023.1161417. eCollection 2023. Front Immunol. 2023. PMID: 37313417 Free PMC article.

5

Age-related changes in the TRB and IGH repertoires in healthy adult males and females.

Gong M, Li X, Zheng A, Xu H, Xie S, Yan R, Wu H, Wang Z. Gong M, et al. Among authors: zheng a. Immunol Lett. 2021 Dec;240:71-76. doi: 10.1016/j.imlet.2021.10.002. Epub 2021 Oct 16. Immunol Lett. 2021. PMID: 34666136

6

The dynamics and association of B and T cell receptor repertoires upon antibody response to hepatitis B vaccination in healthy adults.

Zhao M, Li X, Xie S, Gong M, Yan R, Zheng A, Xu Y, Wu H, Wang Z. Zhao M, et al. Among authors: zheng a. Hum Vaccin Immunother. 2021 Sep 2;17(9):3203-3213. doi: 10.1080/21645515.2021.1913028. Epub 2021 Apr 16. Hum Vaccin Immunother. 2021. PMID: 33861159 Free PMC article.

7

The ¹⁸F-PSMA-1007 PET/CT performance on metastasis status and therapy assessment in oligo-metastasis prostate cancer.

Wang Z, Zheng A, Li Y, Gao J, Dong W, Li Y, Duan X. Wang Z, et al. Among authors: zheng a. Front Oncol. 2022 Aug 26;12:935979. doi: 10.3389/fonc.2022.935979. eCollection 2022. Front Oncol. 2022. PMID: 36091136 Free PMC article.

8

The prognostic value of ¹⁸F-PSMA-1007 PET/CT in predicting pathological upgrading of newly diagnosed prostate cancer from systematic biopsy to radical prostatectomy.

Zheng A, Wang Z, Luo L, Chang R, Gao J, Wang B, Duan X. Zheng A, et al. Front Oncol. 2023 May 10;13:1169189. doi: 10.3389/fonc.2023.1169189. eCollection 2023. Front Oncol. 2023. PMID: 37234988 Free PMC article.

9

Evaluation of a radiomics nomogram derived from Fluoride-18 PSMA-1007 PET/CT for risk stratification in newly diagnosed prostate cancer.

Wang Z, Li Y, Zheng A, Gao J, Yuan W, Shen C, Bai L, Duan X. Wang Z, et al. Among authors: zheng a. Front Oncol. 2022 Nov 15;12:1018833. doi: 10.3389/fonc.2022.1018833. eCollection 2022. Front Oncol. 2022. PMID: 36457489 Free PMC article.

10

¹⁸F-PSMA-1007 PET/CT Performance on Risk Stratification Discrimination and Distant Metastases Prediction in Newly Diagnosed Prostate Cancer.

Wang Z, Zheng A, Li Y, Dong W, Liu X, Yuan W, Gao F, Duan X. Wang Z, et al. Among authors: zheng a. Front Oncol. 2021 Oct 28;11:759053. doi: 10.3389/fonc.2021.759053. eCollection 2021. Front Oncol. 2021. PMID: 34778079 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,575 results

Search Page

Filters